相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of Forkhead- box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
Foluso O. Ademuyiwa et al.
MODERN PATHOLOGY (2010)
Loss of full length CtBP1 expression enhances the invasive potential of human melanoma
Andreas Winklmeier et al.
BMC CANCER (2009)
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Rachael Natrajan et al.
CLINICAL CANCER RESEARCH (2009)
FOXA1 in breast cancer
Harikrishna Nakshatri et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Alterations in the TOP2A and HER2 Genes: Association With Adjuvant Anthracycline Sensitivity in Human Breast Cancers
Dennis J. Slamon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
FoxA1 as a lineage-specific oncogene in luminal type breast cancer
Noritaka Yamaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
High-resolution array CGH clarifies events occurring on 8p in carcinogenesis
Susanna L. Cooke et al.
BMC CANCER (2008)
Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+breast cancer and indicates poor clinical outcome in stage I and II disease
M. W. Helms et al.
BRITISH JOURNAL OF CANCER (2008)
A Range of Cancers Is Associated with the rs6983267 Marker on Chromosome 8
Dominika Wokolorczyk et al.
CANCER RESEARCH (2008)
Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer
Jeong-Yeon Lee et al.
CANCER RESEARCH (2008)
Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population
Kristy E. Driver et al.
CARCINOGENESIS (2008)
Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer
Junichi Matsubara et al.
CLINICAL CANCER RESEARCH (2008)
Absence of ESR1 amplification in a series of breast cancers
Jose Adelaide et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
HER-2 and topoisomerase II as predictors of response to chemotherapy
Kathleen I. Pritchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy
Stephen Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cross-Talk Between the ErbB/HER Family and the Type I Insulin-Like Growth Factor Receptor Signaling Pathway in Breast Cancer
Quanri Jin et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
The genomic profile of HER2-amplified breast cancers: the influence of ER status
C. Marchio et al.
JOURNAL OF PATHOLOGY (2008)
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
Edurne Arriola et al.
LABORATORY INVESTIGATION (2008)
The identification of microRNAs in a genomically unstable region of human chromosome 8q24
Konrad Huppi et al.
MOLECULAR CANCER RESEARCH (2008)
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3
Ian P. M. Tomlinson et al.
NATURE GENETICS (2008)
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Montserrat Garcia-Closas et al.
PLOS GENETICS (2008)
GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation
Tao Bai et al.
CARCINOGENESIS (2008)
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
M. A. Thorat et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Integrated profiling of basal and luminal breast cancers
Jose Adelaide et al.
CANCER RESEARCH (2007)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines
C. Ginestier et al.
ONCOGENE (2007)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer
Yinghui Guan et al.
CLINICAL CANCER RESEARCH (2007)
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity
Paola Di Stefano et al.
EMBO JOURNAL (2007)
Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells
S. C. Pero et al.
BRITISH JOURNAL OF CANCER (2007)
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers
S-F Chin et al.
ONCOGENE (2007)
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
Suet F. Chin et al.
GENOME BIOLOGY (2007)
Gene expression profiling and clinical outcome in breast cancer
Francois Bertucci et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2006)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Koei Chin et al.
CANCER CELL (2006)
C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer
Elizabeth E. Evans et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
Anne Letessier et al.
BMC CANCER (2006)
RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes
Jessica Kao et al.
GENES CHROMOSOMES & CANCER (2006)
Pvclust: an R package for assessing the uncertainty in hierarchical clustering
R Suzuki et al.
BIOINFORMATICS (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer
P Kauraniemi et al.
ENDOCRINE-RELATED CANCER (2006)
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
G Hudelist et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma
LM Shih et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer
L Radvanyi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization
TL Naylor et al.
BREAST CANCER RESEARCH (2005)
Identification and validation of an ERBB2 gene expression signature in breast cancers
F Bertucci et al.
ONCOGENE (2004)
Comparative multi-methodological measurement of ERBB2 status in breast cancer
C Ginestier et al.
JOURNAL OF PATHOLOGY (2004)
Signalling by the type 1 insulin-like growth factor receptor: Interplay with the epidermal growth factor receptor
TE Adams et al.
GROWTH FACTORS (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
JR Pollack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers
C Ginestier et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions
DC Han et al.
ONCOGENE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
